Br J Cancer
- WU R, Arendse KD, Hamdani T, Walter FM, et al
Cost-effectiveness of CA125- and age-informed risk-based triage for ovarian
cancer detection in primary care.
Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03166.
- ARENDSE KD, Walter FM, Abel G, Rous B, et al
CA125 and age-based models for ovarian cancer detection in primary care: a
population-based external validation study.
Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03165.
Clin Cancer Res
- NGOI NYL, Choi CH, Zhu J, Lim D, et al
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell
adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2
trial.
Clin Cancer Res. 2025 Jul 24. doi: 10.1158/1078-0432.CCR-25-0201.
Gynecol Oncol
- CLARKE MA, Wentzensen N, Kobel M, Erickson BK, et al
Age-specific incidence and five-year relative survival of endometrial cancer
histotypes by race and ethnicity among US women, 2000 to 2019.
Gynecol Oncol. 2025;200:137-144.
- BRODSKY AL, Sun C, Cobb L, Westin SN, et al
Ovarian mixed low- and high-grade serous carcinoma as a synchronous or
metachronous phenomenon: A clinicopathologic study of 39 cases.
Gynecol Oncol. 2025;200:130-136.
- HUBINETTE M, Sundstrom-Poromaa I, Persson S, Elenis E, et al
Polycystic ovary syndrome and the risk of ovarian tumours.
Gynecol Oncol. 2025;200:1-7.
Int J Cancer
- ULLAH A, Chen Y, Shen Y, Shen B, et al
Chemotherapy as a double-edged sword: Modulation of tumor-associated cytokine and
chemokine responses in ovarian cancer.
Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70132.
PLoS Genet
- KIM H, Kim Y, Park J, Shin DM, et al
Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer.
PLoS Genet. 2025;21:e1011660.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016